Geoffrey Maltzahn

Venture investor in Cambridge

Invests in AI

Geoffrey Maltzahn's investor profile lists AI alongside Healthcare & Biotech, Biotech & Pharma and Food & Beverage, at Series A. The record holds 57 deals, among them KSQ Therapeutics, Denali Therapeutics and Syros Pharmaceuticals.

Email Investor

Email Investor

Credits to line up before a Series A round

Geoffrey Maltzahn backs companies at Series A. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • KSQ Therapeutics
  • Denali Therapeutics
  • Syros Pharmaceuticals
  • Incredible Foods
  • Inzen Therapeutics
  • Ohana Biosciences
  • T2 Biosystems
  • Tangent Medical Technologies
  • Kaleido BioSciences
  • Permeon Biologics
  • Kovio
  • Oasys Water
  • Editas Medicine
  • Tessera Therapeutics
  • Generate Biomedicines, Inc.
  • Ring Therapeutics
  • Moderna Therapeutics
  • Omega Therapeutics
  • Cygnal Therapeutics
  • Sana Biotechnology
  • Seres Therapeutics
  • Agios Pharmaceuticals
  • Red Rock Biofuels
  • Tarveda Therapeutics
  • Receptos
  • Repertoire Immune Medicines
  • Generate Biomedicines
  • Codiak Biosciences
  • BlackDuck
  • Polatis
  • Seventh Sense Biosystems
  • Sigilon Therapeutics
  • Boragen
  • TARIS Biomedical
  • TransMedics
  • Selecta Biosciences
  • Quanterix
  • Visterra
  • Cobalt Biomedicine, Inc.
  • Sesen Bio, Inc.
  • CiBO Technologies
  • medidametrics
  • Rubius Therapeutics
  • Axcella
  • Senda Biosciences
  • Foghorn Therapeutics
  • Evelo Biosciences
  • Inari
  • Joule Unlimited Technologies
  • Cellarity

Showing 50 of 57 deals on record.

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, Biotech & Pharma, Food & Beverage
Rounds
Series A
Profile
Venture investor
Deals on record
57
Based in
Cambridge, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Geoffrey Maltzahn invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Geoffrey Maltzahn's investor profile, together with Healthcare & Biotech, Biotech & Pharma and Food & Beverage. The stages on record are Series A.
Which companies has Geoffrey Maltzahn backed?
The record lists 57 deals, including KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and Inzen Therapeutics. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Geoffrey Maltzahn?
For a company raising a Series A round, AI Perks lists credits such as Freshworks (up to $10,000), Braintree/PayPal (up to $100,000), PostHog (up to $50,000) and Zendesk (up to $100,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor